Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 5/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | LAP3 | P28838 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5117818 | 1.00 | ALDH1A1 (0.55) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 | |
| SCHEMBL2231648 | 1.00 | ALDH1A1 (0.55) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 | |
| SCHEMBL10727982 | 0.91 | LMNA (0.57) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 | |
| SCHEMBL10727978 | 0.91 | LMNA (0.57) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 | |
| SCHEMBL11182822 | 0.88 | L3MBTL1 (0.50) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 | |
| SCHEMBL3736834 | 0.85 | ATM (0.65) | ALDH1A1TDP1LTA4HLAP3ATM | |
| SCHEMBL22615678 | 0.85 | ATM (0.65) | ALDH1A1TDP1LTA4HLAP3ATM | |
| SCHEMBL11845149 | 0.84 | L3MBTL1 (0.46) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 | |
| SCHEMBL8792364 | 0.84 | PTGS1 (0.52) | ALDH1A1SLC6A2LMNALTA4HLAP3 | |
| Mandelic Acid, Methyl Ester SCHEMBL7704691 | 0.83 | ALDH1A1 (0.50) | ALDH1A1MAPK1TDP1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702633-A | Preparation method of drug chlorinated intermediate for preventing cytomegalovirus infection | 台州职业技术学院 | 2024-09-27 | — | — | CN | claimed |
| CN-118218027-A | Application of polydentate ligand/ruthenium catalyst and method for preparing diol compound by hydrogenation reaction of alpha-hydroxy ester | 郑州大学 | 2024-06-21 | — | — | CN | claimed |
| JP-59098033-A | — | — | None | — | — | JP | disclosed |
| JP-57210889-A | — | — | None | — | — | JP | disclosed |
| US-20250388534-A1 | SUPRAMOLECULAR TRANEXAMIC ACID-MANDELIC ACID IONIC SALT AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | SHENZHEN SHINEHIGH INNOVATION CO., LTD. (CN) | 2025-12-25 | — | — | US | disclosed |
| CN-119930682-A | Novel method for synthesizing rosuvastatin intermediate side chain | 江苏阿尔法集团福瑞药业(宿迁)有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-115403761-B | Multi-glycol modified lipid compound and preparation method and application thereof | 天津键凯科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118843629-A | Antiviral compounds and methods of making and using the same | 吉利德科学公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118702633-A | Preparation method of drug chlorinated intermediate for preventing cytomegalovirus infection | 台州职业技术学院 | 2024-09-27 | — | — | CN | disclosed |
| CN-114410699-B | Method for producing R-mandelic acid by biocatalysis | 安徽泰格生物科技有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-118488948-A | IKAROS zinc finger family degradation agent and application thereof | 吉利德科学公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-1265096-A | Hydrazine derivatives | HOFFMANN LA ROCHE (CH) | 2000-08-30 | — | — | CN | disclosed |
| EP-0993442-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-04-19 | — | — | EP | disclosed |
| WO-1999001428-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-01-14 | — | — | WO | disclosed |
| EP-0554455-A1 | OPTICALLY ACTIVE INTERMEDIATE AND PRODUCTION THEREOF | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1993-08-11 | — | — | EP | disclosed |
| EP-0152083-B1 | PROCESS FOR PRODUCING POWDER OF MICROCAPSULES | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4601863-A | Process for producing powder of microcapsules | KANZAKI PAPER MANUFACTURING CO., LTD. (JP) | 1986-07-22 | — | — | US | disclosed |
| EP-0152083-A2 | Process for producing powder of microcapsules | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1985-08-21 | — | — | EP | disclosed |
| JP-S5998033-A | PREPARATION OF MANDELIC ACID | NIPPON SYNTHETIC CHEM IND CO LTD:THE | 1984-06-06 | — | — | JP | disclosed |
| JP-S57210889-A | HEAT-SENSITIVE RECORDING PAPER | HONSHU PAPER CO LTD | 1982-12-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388534-A1 | SUPRAMOLECULAR TRANEXAMIC ACID-MANDELIC ACID IONIC SALT AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | F7, F8, SLC7A1 | ALDH1A1 1207/4885MAPK1 1330/4885TDP1 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.